Genetics of type 1 diabetes mellitus

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 12, Issue 1, 1999, Pages 3-26

  Friday, R P ^a   Trucco, M ^a   Pietropaolo, M ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Genes; Genetics; Genome wide searches; HLA DQB; IDDM

Indexed keywords

LEUKOCYTE ANTIGEN;

AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELL TYPE; ENVIRONMENTAL FACTOR; FOLLOW UP; GENETIC SUSCEPTIBILITY; GENETICS; GENOME; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ALLELES; CHROMOSOMES, HUMAN, PAIR 6; DIABETES MELLITUS, TYPE 1; GENES, MHC CLASS I; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISLETS OF LANGERHANS; PEDIGREE;

EID: 0032856838     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (181)

1. Warram H.H., Krolewski A.S., Gottlieb M.S., Kahn C.R.: Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N. Engl. J. Med. 311: 149-152, 1984.
2. Warram J.H., Rich S.S., Krolewski A.S.: Epidemiology and genetics of diabetes mellitus. In: Kahn C.R., Weir G.C. (Eds), Joslin's diabetes mellitus. Lea and Febiger, Philadelphia, 1994, pp. 201.
3. Wagener D.K., Sacks J.M., LaPorte R.E., MacGregor J.M.: The Pittsburgh study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM. Diabetes 31: 136-144, 1982.
4. Bleich D., Polak M., Eisenbarth G.S., Jackson R.A.: Decreased risk of type 1 diabetes in offspring of mothers who acquire diabetes during adrenarchy. Diabetes 42: 1433-1439, 1993.
5. Allen C., Palta M., D'Alessio D.J.: Incidence and differences in urban-rural seasonal variation of type 1 (insulin-dependent) diabetes in Wisconsin. Diabetologia 29: 629-633, 1986.
6. Dorman J.S., McCarthy B.J., O'Leary A.L., Koehler A.N.: Risk factors for insulin-dependent diabetes. In: National Institute of Diabetes and Digestive and Kidney Diseases. National Institutes of Health (Eds), Diabetes in America. Bethesda, 1995, pp. 165-177.
7. Warram J.H., Kroleski A.S., Kahn C.R.: Determinants of IDDM and perinatal mortality in children of diabetic mothers. Diabetes 37: 1328-1334, 1988.
8. LaPorte R.E., Matsushima M., Chang Y.-F.: Prevalence and incidence of insulin-dependent diabetes. In: National Institute of Diabetes and Digestive and Kidney Diseases. National Institutes of Health (Eds.), Diabetes in America. Bethesda, 1995, pp. 37-46.
9. Groop L.C., Bottazzo G.F., Doniach D.: Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 35: 237-241, 1986.
10. Landin-Olsson M., Karlsson F.A., Lernmark Å., Sundkvist G., and the Diabetes Incidence Study in Sweden Group: Islet cell and thyrogastric antibodies in 633 consecutive 15-to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 41: 1022-1027, 1992.
11. Rewers M., Hamman R.F.: Risk factors for non-insulin-dependent diabetes mellitus. In: National Institute of Diabetes and Digestive and Kidney Diseases. National Institutes of Health (Eds.), Diabetes in America. Bethesda, 1995, pp. 179-220.
12. Tuomi T., Groop L.C., Zimmet P.Z., Rowley M.J., Knowles W.J., Mackay I.R.: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes in adults with a non-insulin-dependent onset of diabetes. Diabetes 42: 359-362, 1993.
13. Zimmet P.Z., Shaten B.J., Kuller L.H., Rowley M.J., Knowles W.J., Mackay I.R., for UK Prospective Diabetes Study (UKPDS) Group: Antibodies to glutamic acid decarboxylase and diabetes mellitus in the Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 140: 683-690, 1994.
14. Turner R., Stratton I., Horton V., Manley S., Zimmet P., Mackay I.R., Shattock M., Bottazzo G.F., Holman R., for UK Prospective Diabetes Study (UKPDS) Group: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350: 1288-1293, 1997.
15. Allen C., Palta M., D'Alessio D.J.: Risk of diabetes in siblings and other relatives of IDDM subjects. Diabetes 40: 831-836, 1991.
16. Dahlquist G., Blom L., Tuvemo T., Nystrom L., Sandstrom A., Wall S.: The Swedish childhood diabetes study - results from a nine-year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32: 2-6, 1989.
17. Dahlquist G., Blom L., Lonnberg G.: The Swedish childhood diabetes study-a multivariate analysis of risk determinants for diabetes in different age groups. Diabetologia 34: 757-762, 1991.
18. Tuomilehto J., Lounamaa R., Tuomilehto-Wolf E., Reunanen A., Virtala E., Kaprio E.A., Akerblom H.K., and the Childhood Diabetes in Finland (DiMe) Study Group: Epidemiology of childhood diabetes mellitus in Finland -background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 70-76, 1992.
19. Tillil H., Kobberling J.: Age-correlated empirical genetic risk estimates for first degree relatives of IDDM patients. Diabetes 36: 93-99, 1987.
20. Nepom G.T.: Class II antigens and disease susceptibility. In: Annual Reviews Inc. (Eds.), Annu. Rev. Med. 1995, pp. 17-25.
21. Vadheim C.M., Rotter J.I., Maclaren N.K., Riley W.J., Anderson C.E.: Preferential transmission of diabetic alleles within the HLA gene complex. N. Engl. J. Med. 315: 1314-1318, 1986.
22. Dahlquist G.: Environmental risk factors in human type I diabetes - an epidemiological perspective. Diabetes Metab. Rev. 11: 37-46, 1995.
23. Dahl-Jorgensen K., Joner G., Hanssen K.F.: Relationship between cow's milk consumption and incidence of ID-DM in childhood. Diabetes Care. 14: 1081-1083, 1991.
24. Dahlquist G., Ivarsson S., Lindberg B., Forsgren M.: Maternal enteroviral infection during pregnancy as a risk determinant for childhood insulin-dependent diabetes mellitus-a population based case-control study. Diabetes 44: 408-413, 1995.
25. Conrad B., Trucco M.: Superantigens as etiopathogenic factors in the development of insulin dependent diabetes mellitus. Diabetes Metab. Rev. 10: 309-1995.
26. Trucco M., LaPorte R.: Exposure to superantigens as an immunogenetic explanation of type I diabetes mini-epidemics. J. Pediatr. Endocrinol. Metab. 8: 3-10, 1995.
27. Conrad B., Weidmann E., Trucco G., Rudert W.A., Ricordi C., Rodriquez-Rilo H., Behboo R., Finegold D., Trucco M.: Evidence for superantigen involvement in insulin-dependent diabetes mellitus etiology. Nature 371: 351-1994.
28. Strominger J.L.: Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune disease. J. Clin. Invest. 77: 1411-1415, 1986.
29. Lu S.S.S., Tun R.Y.M., Hawa M., Leslie R.D.G.: Studies of diabetic twins. Diabetes Metab. Rev. 7: 223-238, 1991.
30. Bingley P.J., Gale E.A.M.: Rising inidence of IDDM in Europe. Diabetes Care 12: 289-295, 1989.
31. Dorman J.S., LaPorte R.E., Tajima N., Orchard T.J., Becker D.J., Drash A.L.: Differential risk factors for death in insulin-dependent diabetic patients by duration of disease. Pediatr. Adolesc. Endocrinol. 15: 289-299, 1986.
32. Powis S.H., Mockridge I., Kelly A., Kerr L.A., Glynne R., Gilardi U., Beck S., Trowsdale J.: Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc. Natl. Acad. Sci. USA 89: 1463, 1991.
33. Colonna M., Bresnahan M., Bahram S., Strominger J.L., Spies T.: Alleleic variants of the human putative peptide transporter involved in antigen processing. Proc. Natl. Acad. Sci. USA 89: 3932-3936, 1992.
34. Germain R.N.: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287-299, 1994.
35. Schwartz B.D.: Cecil Textbook of Medicine. In: Bennett J.C., Plum F. (Eds.), Cecil Textbook of Medicine. W.B. Saunders Company, Philadelphia, 1996, pp. 1424-1432.
36. Tiwari J.L., Terasaki P.I. HLA and disease associations. Springer-Verlag, New York, 1985.
37. Li H., Llera A., Tsuchiya D., Leder L., Ysern X., Schlievert P.M., Karjalainen K., Mariuzza R.A.: Three-dimentional structure of the complex between a T cell receptor β chain and the superantigen staphylococcal enterotoxin B. Immunity 9: 807-816, 1998.
38. Degli Esposti M.A., Leaver L.A., Christiansen F.T., Witt C.S., Abraham L.J., Dawkins R.L.: Ancestral haplotypes: conserved population MHC haplotypes. Hum. Immunol. 34: 242-252, 1992.
39. Zhang W.J., Degli Esposti M.A., Cobain T.J., Cameron P.U., Christiansen F.T., Dawkins R.L.: Differences in gene copy number carried by different MHC ancestral haplotypes. J. Exp. Med. 171: 2101-2114, 1990.
40. Termijtelen A., D'Amaro J., van Rood J.J., Schreuder G.M.T.: Linkage disequilibrium in HLA cannot be explained by selective recombination. Tissue Antigens 46: 387-390, 1995.
41. Faas S., Trucco M.: The genes influencing the susceptibility to IDDM in humans. J. Endocrinol. Invest. 17: 477-495, 1994.
42. Tisch R., McDevitt H.: Insulin-dependent diabetes mellitus. Cell. 85: 291-297, 1996.
43. Pietropaolo M., Eisenbarth G.S.: Molecular targets of the autoimmunity of type I diabetes. In: Draznin B., LeRoith D. (Eds.), Molecular biology of diabetes. Humana Press Inc., Totowa, NJ, 1994, pp. 1-33.
44. + relatives. The ICARUS Data Set. Diabetes 45: 1720-1728, 1996.
45. Trucco M.: To be or not to be ASP 57, that is the question. Diabetes Care 15: 705-715, 1992.
46. She J.-X.: Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol. Today 17: 323-329, 1996.
47. She J.-X., Marron M.P.: Genetic susceptibility factors in type 1 diabetes: linkage, disequilibrium and functional analyses. Curr. Opin. Immunol. 114: 370-376, 1998.
48. Aitman T.J., Todd J.A.: Molecular genetics of diabetes mellitus. Baillieres Clin. Endocrinol. Metab., 631-656, 1995.
49. Owerbach D., Gabbay K.H.: The search for IDDM susceptibility genes: the next generation. Diabetes 45: 544-551, 1996.
50. Lipes M., Eienbarth G.S.: Transgenic Mouse Models of Type I Diabetes. Diabetes 39: 879-884, 1990.
51. Platz P., Jacobsen B.K., Morling N., Ryder L.P., Sveygaard A., Thomsen M., Cristy M., Kromann H., Benn J., Nerup J.: HLA-D and HLA-DR antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 1108-1115, 1981.
52. Wolf E., Spencer K.M., Cudworth A.G.: The genetic susceptibility to Type I (insulin dependent) diabetes: analysis of the HLA-DR association. Diabetologia 24: 224-230, 1983.
53. Walker A., Cudworth A.G.: Type I (insulin-dependent) diabetic multiplex families: mode of genetic transmissions. Diabetes 33: 176-183, 1983.
54. Nerup J.J., Platz P., Anderson O., Christy M., Lyngsoe J., Poulsen J., Ryder L., Staub Nielsen L., Thomsen M., Svejgaard A.: HLA antigens and diabetes mellitus. Lancet 2: 864-1974.
55. Cudworth A.G., Woodrow J.C.: Genetic susceptibility in diabetes mellitus: analysis of the HLA association. Lancet 2: 846-850, 1976.
56. Barbosa J., Chern M.M., Reinsmoen N., Noreen H., Ramsay R., Greenberg L.: HLA-Dw antigens in unrelated juvenile, insulin-dependent diabetics. Tissue Antigens 14: 426-430, 1979.
57. Sachs J.A., Cudworth A.G., Jaraquemada D., Gorusch A.N., Festenstein, H.: Type I diabetes and the HLA-D locus. Diabetologia 18: 41-47, 1980.
58. Schreuder G., Tilanus M.G., Bontrop R.E., Bruining G.J., Griphart M.J., van Rood J.J., de Vries R.R.: HLA-DQ polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences and restriction fragment length polymorphism. J. Exp. Med. 938-1986.
59. Trucco M., Ball E.: RFLP analysis of DQ beta chain gene: Workshop report. In: (Eds.), Histocompatibility testing. Springer-Verlag, Heidelberg, 1989, pp. 860-867.
60. Owerbach D., Gunn S., Ty G., Wible L., Gabbay K.H.: Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to Type I (insulin-dependent) diabetes mellitus. Diabetologia 31: 751-757, 1988.
61. Eisenstein B.I.: The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis. N. Engl. J. Med. 322: 178-183, 1990.
62. Todd J.A., Bell J.I., McDevitt H.O.: HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604, 1987.
63. Todd J.A., Acha-Orbea H., Bell J.I., Chao N., Fronek Z., Jacob C.O., McDermott M., Sinha A.A., Timmerman L., Steinman L., McDevitt H.O.: A molecular basis for MHC class II associated autoimmunity. Science 240: 1003-1009, 1988.
64. Morel P.A., Dorman J.S., Todd J.A., McDevitt H.O., Trucco M.: Aspartic acid at position 57 of the HLA-DQβ chain protects against Type I diabetes: a family study. Proc. Natl. Acad. Sci. USA 85: 8111-8115, 1988.
65. Khalil I., D'Auriol L., Gobet M., et al: A combination of HLA-DQ beta Asp 57-negative and HLA-DQ Arg 52 confers susceptibility to insulin-dependent diabetes mellitus. J. Clin. Invest. 85: 1315-1319, 1990.
66. Svejgaard A., Platz P., Ryder L.: HLA and disease 1982: a survey. Immunol. Rev. 70: 193-198, 1983.
67. Svejgaard A., Jakobsen B.K., Plat P., Ryder L.P., Nerup J., Christy M., Borch-Johnsen K., Parving H.-H., Deckert T., Molsted-Pedersen L., Kuhl C., Buschard K., Green A.: HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogenous population. Tissue Antigens 28: 237-244, 1986.
68. Dalton T.A., Bennet J.C.: Autoimmune disease and the major histocompatibility complex: Therapeutic implications. Am. J. Med. 92: 183-188, 1992.
69. Owerbach D., Lernmark A., Platz P., Ryder L.P., Rask L., Peterson P.A., Ludvigsson J.: HLA-D region beta chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin dependent diabetic individuals. Nature 303: 815-817, 1983.
70. Cohen-Haguenaur O., Robbins E., Massart C., Busson M., Deschamps I., Hors J., Lalouel M.J., Dausset J., Cohen D.: A systematic study of HLA class II beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 82: 3335-3339, 1985.
71. Sheehy M.J., Scharf S.J., Rowe J.R., Neme de Gimenez M.H., Meske L.M., Erlich H.A., Nepom B.S.: A diabetes susceptible HLA haplotype is best defined by a combination of HLA-DR and DQ alleles. J. Clin. Invest. 83: 830-835, 1989.
72. Sheehy M.J.: HLA and insulin-dependent diabetes: a protective perspective. Diabetes 41: 123-129, 1992.
73. Nepom G.T., Erlich H.: MHC class-II molecules and autoimmunity. Ann. Rev. Immunol. 9: 493-525, 1991.
74. Erlich H.A., Bugawan T.L., Scharf S., Nepom G.T., Tait B., Griffith R.L.: HLA-DQβ sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39: 96-103, 1990.
75. Tait B.D., Drummond B.P., Varney M.D., Harrison L.C.: HLA-DRB1*0401 is associated with susceptibility to insulin-dependent diabetes mellitus independently of the DQB1 locus. Eur. J. Immunogenet. 22: 289-297, 1995.
76. Cucca F., Muntoni F., Lampis R., Frau F., Argiolas L., Silvetti M., Angius E., Cao A., De Virgilis S., Congia M.: Combination of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum. Immunol. 37: 85-94, 1993.
77. Yasunaga S., Kimura A., Hamaguchi H., Sasazuki T.: Different contribution of HLA-DR and DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 47: 37-48, 1996.
78. Sanjeevi C.B., Hook P., Landin-Olsson M., Kockum I., Dahlquist G., Lybrand T.P., Lernmark Å.: DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes. Tissue Antigens 275-283, 1996.
79. Thomson G., Robinson W.P., Kuhner M.K., Joe S., MacDonald M.J., Gottschall J.L., Barbosa J., Rich S.S., Bertrams J., Baur M.P., Partanena J., Tait B.D., Schober E., Mayr W.R., Ludvigsson J., Lindblom B., Farid N.R., Thompson C., Deschamps I.: Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 43: 799-816, 1988.
80. Thomson G., Robinson W.P., Kuhner M.K., Joe S., Klitz, W.: HLA and insulin gene associations with IDDM. Genet. Epidemiol. 6: 155-160, 1989.
81. Horn G.T., Bugawan T.L., Long C.M., Erlich H.A.: Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes mellitus susceptibility. Proc. Natl. Acad. Sci. USA 85: 6012-6016, 1988.
82. Baisch J.M., Weeks T., Giles R., Hoover M., Stastny P., Capra J.D.: Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322: 1836-1841, 1990.
83. Sorrentino R., DeGrazia U., Buzzetti R., Nistico L., Iannicola C., Costanzi S., Tosi R.: An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes 41: 904-908, 1992.
84. Rønningen K.S., Spurkland A., Iwe T., Vartdal F., Thorsby E.: Distribution of HLA-DRB1,-DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 37: 105-111, 1991.
85. th international histocompatibility workshop and conference (Vol I). Oxford University Press, Oxford, 1992, pp. 713-722.
86. Zeliszewski D., Tiercy J., Boitard C., Gu X., Loche M., Krishnamoorthy R., Simonney N., Elion J., Bach J.F., Mach B., Sterkers, G.: Extensive study of DRβ, DQα, and DQβ gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients. Hum. Immunol. 33: 140-147, 1992.
87. Ziegler A.G., Ziegler R., Vardi P., Jackson R.A., Soeldner J.S., Eisenbarth G.S.: Life table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 38: 1320-1325, 1989.
88. Lipton R.B., Kocova M., LaPorte R.E., Dorman J.S., Orchard T.J., Riley W.J., Drash A.L., Becker D.J., Trucco M.: Autoimmunity and genetic factors contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am. J. Epidemiol. 136: 503-512, 1992.
89. Gutierrez-Lopez M.D., Bertera S., Chantres M.T., Vavassori C., Dorman J.S., Trucco M., Serrano-Rios M.: Susceptibility to type I diabetes in Spanish patients correlates quantitatively with expression of HLA-DQα Arg 52 and HLA-DQβ non-Asp 57 alleles. Diabetologia 35: 583-1992.
90. Khalil I., Deschamps I., Lepage V., Al-Daccak R., Degos L., Hors J.: Dose effect of Cis- and Trans-Encoded HLA-DQalpha/beta heterodimers in IDDM susceptibility. Diabetes 41: 378-384, 1992.
91. Erlich H.A., Zeidler A., Chang J., Shaw S., Raffel L.J., Klitz W., Beshkov Y., Costin G., Pressman S., Bugawan T., Rotter J.I.: HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat. Genet. 3: 358-364, 1993.
92. Eisenbarth G.S.: Type I diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 314: 1360-1368, 1986.
93. Pietropaolo M., Rudert W.A., LaPorte R.E., Becker D.J., Trucco M.: Four HLA-DQ heterodimers are potent risk factors for IDDM in the absence of GAD65, IA-2 and Islet Cell Antibodies. Diabetes 47 (Suppl. 1): A209. 1998.
94. Pietropaolo M., Becker D.J., Dorman J.S., LaPorte R.E., Mazumdar S., Rudert W.A., Trucco M.: Are GAD65 and IA-2 autoantibodies sufficient to predict Type 1 diabetes? Diabetes 48 (Supp. 1): 193. 1999.
95. Thorsby E., Rønningen K.S.: Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus. Ann. Med. 24: 523-531, 1992.
96. Thorsby E., Rønningen K.S.: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type I (insulin-dependent) diabetes mellitus. Diabetologia 36: 371-377, 1993.
97. Thorsby E.: Invited anniversary review: HLA associated diseases. Hum. Immunol. 53: 1-11, 1997.
98. Kockum I., Wassmuth R., Holmberg E., Michelsen B., Lernmark Å.: HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls. Am. J. Hum. Genet. 53: 150-167, 1993.
99. Kockum I., Dahlquist G., Falorni A., Hagopian W.A., Landin-Olsson M., Li L.C., Luthman H., Palmer J.P., Sanjeevi C.B., Östman J., and The Swedish Childhood Diabetes Study Group and the Diabetes Incidence in Sweden Study (DISS) Group.: Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. Horm. Metab. Res. 28: 344-347, 1996.
100. Cucca F., Lampis R., Frau F., Macis D., Angius E., Masile P., Chessa M., Frongia P., Silvetti M., Cao A.: The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Hum. Immunol. 43: 301-308, 1995.
101. Awata T., Kuzuya T., Matsuda A., Iwamoto Y., Kanazawa Y., Okuyama M., Juji T.: High frequency of aspartic acid at position 57 of HLA-DQ (5-chain in Japanese ID-DM patients and non-diabetic subjects. Diabetes 39: 266-269, 1990.
102. Penny M.A., Jenkins D., Mijovic C.H., Jacobs K.H., Cavan D.A., Yeung V.T.F., Cockram C.S., Hawkins Br.R., Fletcher J.A., Barnett A.H.: Susceptibility to IDDM in a Chinese population: role of HLA class II alleles. Diabetes 41: 914-919, 1992.
103. Huang H.S., Peng J.T., She J.Y., Zhang L.P., Chao C.C., Liu K.H., She J.-X.: HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibrium in a Chinese population. Hum. Immunol. 44: 210-219, 1995.
104. Awata T., Kuzuya T., Matsuda A., Iwamoto Y., Kanazawa Y.: Genetic analysis of HLA class II alleles and susceptibility to type I (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35: 419-424, 1992.
105. Morales P., Martinez-Laso J., Martin-Villa J.M., Corell A., Vicario J.L., Varela P., Perez-Aciego P., Arnaiz-Villena, A.: High frequency of the HLA-DRB1*0405(Dw 15)-DQw8 haplotype in Spaniards and its relationship to diabetes susceptibility. Hum. Immunol. 32: 170-175, 1991.
106. Van der Auwera B., Van Waeyenberge C., Schuit P., Heimberg H., Vanderwalle C., Gorus F., Flament J.: DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1* 0201 genotype. Belgian Diabetes Registry. Diabetes 44: 527-530, 1995.
107. Baekkeskov S., Aanstoot H., Christgau S., Reetz A., Solimena M.S., Cascalho M., Folli F., Richter-Olsen H., DeCamilli P.: Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990.
108. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L.: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339, 1983.
109. Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oles J., Hicks J.M., Goldstein D.E., Rae P.M.M.: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol. 152: 3183-3188, 1994.
110. Lan M.S., Lu J., Goto Y., Notkins A.L.: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13: 505-514, 1994.
111. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase P.H., Eisenbarth G.S.: Prediction of type I diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512bdc/ IA-2 autoantibodies. Diabetes 45: 926-933, 1996.
112. Pietropaolo M., Peakman M., Pietropaolo S.L., Zanone M.M., Foley T.P., Becker D.J., Trucco M.: Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J. Autoimmun. 11: 1-10, 1998.
113. Falorni A., Kassi G., Murdolo G., Calcinaro F.: Controversies on humoral immune markers of insulin-dependent diabetes mellitus. J. Pediatr. Endocrinol. Metab. 11: 307-317, 1998.
114. Ziegler A.G., Hummel M., Schenker M., Bonifacio E.: Autoantibody appearance and risk for development of childhood diabetes in offspring parents with Type 1 diabetes. The 2-year analysis of the German BABYDIAB study. Diabetes 48: 460-468, 1999.
115. Bingley P.J., Bonifacio E., Williams A.J.K., Genovese S., Bottazzo G.F., Gale E.A.M.: Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers. Diabetes 46: 1710-1997.
116. Ziegler R., Alper C.A., Awdeh Z.L., Castano L., Brink S.J., Soeldner J.S., Jackson R.A., Eisenbarth G.S.: Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first degree relatives of patients with type I diabetes. Diabetes 40: 709-714, 1991.
117. Sanjeevi C.B., Lybrand T.P., DeWeese C., Landin-Olsson, M., Kockum I., Dahlquist G., Sundkvist G., Stenger D., Lernmark A., Swedish Childhood Diabetes Study.: Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Diabetes 44: 125-131, 1995.
118. Kockum I., Sanjeevi C.B., Eastman S., Landin-Olsson M., Dahlquist G., Lernmark Å.: Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls. Eur. J. Immunogenet. 22: 443-465, 1995.
119. Sanjeevi C.B., DeWeese C., Landin-Olsson M., Kockum I., Dahlquist G., Lernmark Å., Lybrand T.P.: Analysis of critical residues if HLA-DQ6 molecules in insulin-dependent diabetes mellitus. Tissue Antigens 50: 61-65, 1997.
120. NOD to the development of insulitis in non-obese diabetic mice. Nature 345: 722-724, 1990.
121. Slattery R.M., Kjer-Nielsen L., Allison J., Charlton B., Mandel T.E., Miller J.F.A.P.: Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature 345: 724-726, 1990.
122. Lund T., O'Reilly L., Hutchings P., Kanagawa O., Simpson E., Gravely R., Chandler P., Dyson J., Picard J.K., Edwards A., Kioussis D., Cook A.: Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta chain or normal I-E alpha chain. Nature 345: 727-729, 1990.
123. Nishimoto H., Kikutani H., Yamamura K., Kishimoto T.: Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328: 432-434, 1987.
124. Boitard C., Bendelac A., Richard M.F., Carnaud C., Bach J.F.: Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc. Natl. Acad. Sci. USA 85: 9719-9723, 1988.
125. Brown J.H., Jardetzky T., Saper M.A., Samraoui B., Bjorkman P.J., Wiley D.C.: A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 332: 845-850, 1988.
126. Brown J.H., Jardetzky T.S., Gorga J.C., et al: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33-39, 1993.
127. Demotz S., Grey H.M., Sette A.: The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249: 1028-1990.
128. von Boehmer H.: Positive selection of lymphocytes. Cell 76: 219-1994.
129. Nossal G.J.V.: Negative selection of lymphocytes. Cell 76: 229-1994.
130. Davey M.P., Meyer M.M., Bakke A.C.: T cell receptor Vβ gene expression in monozygotic twins: discordance in CD8 subset and in disease states. J. Immunol. 152: 315-1994.
131. Nepom G.T., Kwok W.T.: Molecular basis for HLA-DQ association in IDDM. Diabetes 47: 1177-1998.
132. Carcassi C., Trucco G., Trucco M., Contu L.: A new HLA-DR2 extended haplotype is involved in IDDM susceptibility. Hum. Immunol. 31: 159-1991.
133. Pugliese A.: Genetic protection from insulin-dependent diabetes mellitus. Diabetes Nutr. Metab. 10: 169-179, 1997.
134. Eisenbarth G.S., Pietropaolo M.: Prediction and prevention of type I diabetes mellitus. Contemporary Internal Medicine 4: 15-30, 1992.
135. Pietropaolo M., Trucco M.: Major histocompatibility locus and other genes that determine the risk of Type I diabetes mellitus. In: LeRoith D. Olefsky J.M. Taylor S.I. (Eds), Diabetes Mellitus: A Fundamental and Clinical Text. Lippincott Williams & Wilkins, Philadelphia (in press).
136. Pugliese A., Kawasaki E., Zeller M., Yu L., Babu S., Solimena M., Moraes C.T., Pietropaolo M., Friday R.P., Trucco M., Ricordi C., Allen M., Noble J.A., Erlich H.A., Eisenbarth G.S.: Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with Type 1 diabetes. J. Clin. Endocrinol. Metab., 84: 1722-1728, 1999.
137. Bell G.I., Karam J.H., Rutter W.J.: Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc. Natl. Acad. Sci. USA 78: 5759-5763, 1981.
138. Rotwein P., Chyn R., Chirgwin J., Cordell B., Goodman H.M., Permutt M.A.: Polymorphism in the 5'-flanking region of the human insulin gene and its possible relation to Type II diabetes. Science 213: 1117-1120, 1981.
139. Owerbach D., Nerup J.: Restriction fragment length polymorphism of the insulin gene in diabetes mellitus. Diabetes 31: 275-277, 1982.
140. Julier C., Hyer R.N., Davies J., Merlin F., Soularue P., Briant L., Cathelineau G., Deschamps I., Rotter J.I., Froguel P., Boitard C., Bell J.I., Lathrop G.M.: Insulin-IGF2 region encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 354: 155-159, 1991.
141. Bain S.C., Prins J.B., Hearne C.M., Rodrigues N.R., Rowe B.R., Pritchard L.E., Ritchie R.J., Hall J.R.S., Undlien D.E., Ronningen K.S., Dunger D.B., Barnett A.H., Todd J.A.: Insulin gene region-encoded susceptibility to type I diabetes is not restricted to HLA-DR4-positive individuals. Nat. Genet. 2:212-215, 1992.
142. Bennett S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E., Pritchard L.E., Merriman M.E., Kawaguchi Y., Dronsfield M.J., Pociot F., Nerup J., Bouzekri N., Cambon-Thomsen A., Ronningen K.S., Barnett A.H., Bain S.C., Todd J.A.: Susceptibility to human type I diabetes at ID-DM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9: 284-292, 1995.
143. Bennett S.T., Wilson A.J., Cucca F., Nerup J., Pociot F., McKinney P.A., Barnett A.H., Bain S.C., Todd J.A.: IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J. Autoimmun. 9: 415-421, 1996.
144. Bennett S.T., Wilson A.J., Esposito L., Bouzekri N., Undlien D.E., Cucca F., Nisticò L., Buzzetti R., the IMDIAB Group, Bosi E., Pociot F., Nerup J., Cambon-Thomsen A., Pugliese A., Shield J.P.H., McKinney P.A., Bain S.C., Polychronakros C., Todd J.A.: Insulin VNTR allele-specific in type 1 diabetes depends on identity of untransmitted paternal allele. Nat. Genet. 17: 350-352, 1997.
145. Lucassen A.M., Screaton G.R., Julier C., Elliot T.J., Lathrop M., Bell J.I.: Regulation of insulin gene expression by the IDDM associated, insulin locus haplotype. Hum. Mol. Genet. 4: 501-506, 1994.
146. Kennedy G.C., German M.S., Rutter W.J.: The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat. Genet. 9: 293-298, 1995.
147. Krontiris T.G.: Minisatellites and human disease. Science 269: 1682-1683, 1995.
148. Krontiris T.G., Delvin B., Karp D.D., Robert N.J., Risch N.: An association between the risk of cancer and mutation in the HRAS1 minisatellite locus. N. Engl. J. Med. 329: 517-523, 1993.
149. Kiaris H., Spandidos D.A., Jones A.S., Vaughan E.D., Field J.K.: Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck. Br. J. Cancer 72: 123-128, 1995.
150. Wang Y.H., Griffith J.: Expanded CTG triplet block from the myotonic dystrophy gene create the strongest known nucleosome positioning elements. Nat. Genet. 25: 570-573, 1995.
151. McGinnis R.E., Spielman R.S.: Insulin expression: is VNTR allele 698 really anomalous? Nat. Genet. 10: 378-380, 1995.
152. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., Reed P.W., Gough S.C.L., Jenkins S.C., Palmer S.M., Balfour K.M., Rowe B.R., Farrall M., Barnett A.H., Bain S.C., Todd J.A.: A genome-wide search for human type I diabetes susceptibility genes. Nature 371: 130-136, 1994.
153. Cordell H.J., Todd J.A., Bennett S.T., Kawaguchi Y., Farrall M.: Two-locus maximum lod score analysis of a multifactorial trait: joint consideration of IDDM2 and IDDM4 with IDDM1 in type I diabetes. Am. J. Hum. Genet. 57: 920-934, 1995.
154. Todd J.A.: Genetic analysis of type 1 diabetes using whole genome approaches. Proc. Natl. Acad. Sci. (USA) 92: 8560-8565, 1995.
155. Thomson G.: Identifying complex disease genes: progress and paradigms. Nat. Genet. 8: 108-110, 1994.
156. Thomson G.: Strategies involved in mapping diabetes genes: an overview. Diabetes Rev. 5: 106-115, 1997.
157. Lander E.S., Kruglyak L.: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11: 241-247, 1995.
158. Morahan G., Huang D., Tait B.D., Colman P.G., Harrison L.C.: Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 272: 1811-1813, 1996.
159. Van der Auwera B.J., Vanderwalle C.L., Schuit F., Winnock F., De Leeuw I.H., Van Imschoot S., Lamberigts G., Gorus F.K.: CTL-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clin. Exp. Immunol. 110: 98-103, 1997.
160. Mein C.A., Esposito L., Dunn M.G., Johnson G.C.L., Timms A.E., Goy J.V., Smith A.N., Sebag-Montefiore L., Merriman M.E., Wilson A.J., Pritchard L.E., Cucca F., Barnett A.H., Bain S.C., Todd J.A.: A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat. Genet. 19: 297-300, 1998.
161. Concannon P., Gogolin-Ewens K.J., Hinds D.A., Wapelhorst B., Morrison V.A., Stirling B., Mitra M., Farmer J., Williams S.R., Cox N.J., Bell G.I., Risch N., Spielman R.S.: A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat. Genet. 19: 292-296, 1998.
162. Lernmark Å., Ott, J.: Sometimes it's hot, sometimes it's not. Nat. Genet. 19: 213-214, 1998.
163. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddson W.E., McFarland H.F., Trent J.M.: Clustering on non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. (USA) 95: 9979-8894, 1998.
164. Tsao B.P., Cantor R.M., Kalunian K.C., Chen C.J., Badsha H., Singh R., Wallace D.J., Kitridou R.C., Chen S.L., Shen N., Song Y.W., Isenberg D.A., Yu C.L., Hahn B.H., Rotter J.I.: Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J. Clin. Invest. 99: 725-731, 1997.
165. Brown M.A., Pile K.D., Kennedy L.G., Campbell D., Andrew L., Shatford J.L., Weeks D.E., Calin A., Wordsworth B.P.: A genome-wide screen for susceptibility candidate loci in ankylosing spondylitis. Arthritis Rheum. 41: 588-595, 1998.
166. Morel L., Rudofsky U.H., Longmate J.A., Schiffenbauer J., Wakeland E.K.: Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229, 1995.
167. Kono D.H., Burlingame R.W., Owens D.G., Kuramochi A., Balderas R.S., Balomenos D., Theofilopoulos A.N.: Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. (USA) 91: 10168-19172, 1994.
168. Gottlieb P.A., Eisenbarth G.S.: Diagnosis and treatment of pre-insulin dependent diabetes. Annu. Rev. Med. 49: 391-405, 1998.
169. Gaffney P.M., Kearns G.M., Shark K.B., Ortmann W.A., Selby S.A., Malmgren M.L., Rohlf K.E., Ockenden T.C., Messner R.P., King R.A., Rich S.S.: A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc. Natl. Acad. Sci. (USA) 95: 14875-14879, 1998.
170. Daniels S.E., Bhattacharrya S., James A., Leaves N.I., Young A., Hill M.R., Faux J.A., Ryan G.F., le Souf P.N., Lathrop G.M., Musk A.W., Cookson W.O.: A genomewide search for quantitative trait loci underlying asthma. Nature 383: 247-250, 1996.
171. Haines J.L., Ter-Minassian M., Bazyk A., Gusella J.F., Kim D.J., Terwedow H., Pericak-Vance M.A., Rimmler J.B., Haynes C.S., Roses A.D., Lee A., Shaner B., Menold M., Seboun E., Fitoussi R.P., Gartioux C., Reyes C., Ribierre F., Gyapay G., Weissenbach J., Hauser S.L., Goodkin D.E., Lincoln R., Usuku K., Oksenberg J.R.: A complete genome screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13: 469-471, 1996.
172. Collins A., Frezal J., Teague J., Morton N.E.: A metric map of humans: 23,500 loci in 850 bands. Proc. Natl. Acad. Sci. USA 93: 14771-14775, 1998.
173. Lucassen A.M., Julier C., Beressi J.P., Boitard C., Frouguel P., Lathrop M., Bell J.I.: Susceptibility to insulin dependent diabetes maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat. Genet. 4: 305-310, 1993.
174. Halminen M., Veijola R., Reijonen H., Ilonen J., Äkerblom H.K., Knip M., The childhood diabetes in Finland (DiMe) study group.: Effect of polymorphism in the insulin gene region on IDDM susceptibility and insulin secretion. Eur. J. Clin. Invest. 26: 847-852, 1996.
175. Vafiadis P., Bennett S.T., Todd J.A., Grabs R., Polychronakros C.: Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes. J. Clin. Endocrinol. Metab. 83: 2933-2939, 1998.
176. Sattar M.A., Al-Sughyer A.A., Siboo R.: Coexistence of rheumatoid arthritis, ankylosing spondylitis and dermatomyositis in a patient with diabetes mellitus and the associated linked HLA antigens. Br. J. Rheumatol. 27: 146-149, 1988.
177. Yamato E., Ikegami H., Kawaguchi Y., Fujisawa T., Hamada Y., Ueda M., Shintani M., Ogihara T.: Insulin-dependent diabetes mellitus associated with autoimmune thyroiditis and rheumatoid arthritis. Am. J. Med. Sci. 313: 64-66, 1997.
178. Rose N.R.: Autoimmune disease-tracing the shared threads. Hosp. Pract. 32: 147-154, 1997.
179. Rose N.R.: Immunological diagnosis of autoimmunity. In: Leffel M.S., Donnenberg A.D., Rose N.R. (Eds), Handbook of immunology. CRC Press, New York, 1997, pp. 111-123.
180. Cucca F., Goy J.V., Kawaguchi Y., Esposito L., Merriman M.E., Wilson A.J., Cordell H.J., Bain S.C., Todd J.A.: A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat. Genet. 19: 301-302, 1998.
181. Lipton R.B., Atchison J., Dorman J.S., Duquesnoy R.J., Eckenrode K., Orchard T.J., LaPorte R.E., Riley W.J., Kuller L.H., Drash A.L., Becker D.J.: Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in families. Diab. Med. 9: 224-232, 1991.